Infections relating to medical implants such as catheters, stents and joint prosthesis can result in local and systemic infection, implant replacement, patient pain and discomfort and associated healthcare costs. An improvement in the antimicrobial nature of medical implants helps to improve patient well-being and minimise healthcare costs. Please contact Perfectus Biomed to discuss how we can support research and development programmes related to infection control on medical devices. Perfectus Medical Devices (UK) 2
Our testing experience includes working with:
- Catheter tubing
- Catheter bags
- Negative pressure wound therapy devices
- Implantable medical devices
- Point of care diagnostic devices
- 510(k) submission
We offer a range of customised test methodologies which include:
- Biofilm prevention assays
- Biofilm removal assays
- Bacterial percentage coverage analysis
- LIVE/DEAD imaging
- Confocal microscopy
- Scanning Electro Microscopy (SEM)
- Disinfection efficacy analysis
We also offer a range of standard test methodologies including:
- ASTM D7907: Standard test methods for determination of bactericidal efficacy on the surface of medical examination gloves
- BS EN 1616: Sterile urethral catheters for single use
- BS EN ISO 11737-1: Sterilisation of Medical devices – Microbiological Methods – Part 1: Determination of a population of microorganisms on products (Bioburden)
- ISO 22196: Measurement of antibacterial activity on plastics and other non-porous surfaces
- WHTM 01-01: Decontamination of medical devices within acute services
Our library of test organism includes…
Choose from our library of test organism including standard reference strains, clinical isolates and environmental isolates.
Single or mixed species assays containing:
Acinetobacter baumannii, Actinomyces naeslundii, Adenovirus (human), Aspergillus brasiliensis, Aspergillums niger, Aureobasidium pullulans, Bacillus cereus, Bacillus subtilis, Camplylobacter jejuni, Candida albicans, Clostridium difficile, Corynebacterium minutissimum, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium (VRE), Enterococcus hirae, Escherichia coli, Fusobacterium nucleatum, Haemophilus influenzae, Heliocbacter pylori, Halomonas magadiensis, Klebsiella pneumoniae, Lactobacillus casei, MRSA, Neisseria gonorrhoeae, Neisseria subflava, Porphyromonas ginigvalis, Prevotella nigrescens, Propionibacterium acnes, Proteus mirabilis, Pseudomonas aeruginosa, Salmonella enteritidis, Shigella dysenteriae, Staphylococcus aureus (MRSA and MSSA), Staphylococcus epidermidis, Staphylococcus haemolyticus, Stenotrophomonas maltophilia, Streptococcus mutans, Streptococcus oralis, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus zooepidemicus, Tannerella forsythia, Trichophyton rubrum, Veillonella dispar. WHO Priority organisms. Other- please ask.
- Innovate UK Funding Competition Winners!
- EPUAP 2017
- UKAS Accreditation Successfully Maintained!
- In-Cosmetics Formulation Summit 2017
- IPS Conference 2017
- Eurobiofilms 2017
- Perfectus Biomed Featured on the Pan European Network
- ISO 9001:2015 Recertification Success!
- Biofilm Science and Technology Meeting 2017 – CBE
- ICPIC 2017: Infection Conference on Prevention & Infection Control